Viridian Therapeutics Inc. (VRDN)
NASDAQ · Healthcare
Viridian Therapeutics Inc. annual/quarterly long term debt history from 2017 to 2024. Long term debt refers to financial obligations that are due more than one year in the future.
- Viridian Therapeutics Inc. long term debt for the quarter ending December 31, 2024 were 20.6M, a 1.87% increase year-over-year.
- Viridian Therapeutics Inc. long term debt for 2024 were 20.6M, a 1.87% increase from 2023.
- Viridian Therapeutics Inc. long term debt for 2023 were 20.2M, a 334.98% increase from 2022.
- Viridian Therapeutics Inc. long term debt for 2022 were 4.6M, a 39.42% decrease from 2019.
- Viridian Therapeutics Inc. long term debt for 2019 were 7.7M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Viridian Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2024 | $21 |
| 2023 | $20 |
| 2022 | $5 |
| 2019 | $8 |
| 2018 | $10 |
| 2017 | $10 |
| Viridian Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2024-12-31 | $21 |
| 2023-12-31 | $20 |
| 2022-12-31 | $5 |
| 2019-12-31 | $8 |
| 2018-12-31 | $10 |
| 2017-12-31 | $10 |
Viridian Therapeutics Inc. Long Term Debt — FAQ
Viridian Therapeutics Inc. (VRDN) long term debt over the last 13 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see VRDN's long term debt history?
The chart and table above show Viridian Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.